Navigation Links
DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks
Date:8/20/2009

The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).

Horsham, PA, USA (Vocus) August 20, 2009 -- The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).

This three-day workshop will feature interactive discussions with government, biopharmaceutical, medical device, and data standards experts on how to ensure compliance and improve efficiency in clinical trial disclosure.

FEATURED TOPICS

 
  • Global Requirements, Laws, Regulations and Business Cases
  • Defining the Clinical Trial Disclosure Role within a Company
  • Available Tools, Resources, Organizations
  • Impact of External Stakeholders, Company Policies, and Advanced Technologies on
  • Disclosure Processes
  • Key Milestones for Managing Compliance
  • Quality Checks
"Evolving clinical trial registration and results disclosure requirements are significantly increasing the workload of clinical operations and medical affairs departments," says Program Co-chair Tracy Beck, PhD, Associate Global Medical Business Office Consultant; CTR Results Gatekeeper, Eli Lilly and Company. "This workshop will present real-world approaches to the clinical trial registration and results disclosure process."

A preconference tutorial titled, Clinical Trial Results Registration, will be held on October 6. This hands-on tutorial is designed to guide participants in creating accurate and effective study results to www.ClinicalTrials.gov.

For tabletop exhibit opportunities contact Jeff Korn at Jeff.Korn(at)diahome(dot)org.

Click here to register for the 3rd Annual Clinical Trial Disclosure Workshop.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski(at)diahome(dot)org

# # #

Read the full story at http://www.prweb.com/releases/DIA/clinical_trial_disclosure/prweb2775064.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Florida Gentle Dental Dentists Giving Away Smile Makeover and Orthodontic Braces at 7th Annual Our Kids World Family Fun Festival
2. Lightspeed Research -- The Foresight Group, Announced Today the Annual Meeting for The Healthcare Consortium
3. Kuvan and Naglazyme Data to Be Presented at the 11th Annual ICIEM Meeting
4. Rodman Renshaw Annual Global Investment Conference in New York on September 10, 2009
5. Eva Longoria Parker and George Lopez Return to Host 9th Annual PADRES Contra El Cancers EL SUENO DE ESPERANZA Gala
6. The Dannon Company Awards Cornell Cooperative Extension of Westchester County the Fourth Annual Dannon Next Generation Nutrition Grant
7. The Dannon Company Awards Fourth Annual Dannon Next Generation Nutrition Grants Supporting Nutrition Education for Children
8. Sebastian Ferrero Foundation to Host 2nd Annual Fundraiser, Noche de Gala
9. Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention
10. VA Secretary Addresses 65th Annual AMVETS Convention
11. Scott Hamiltons Return to the Ice Scheduled for the 10th Annual An Evening With Scott Hamilton and Friends on Saturday, Nov. 7, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks 
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, ... Murthy explains how he was inspired to practice medicine at an early age by ... about more than making diagnoses and prescribing medicine,” he states. “It is about building ...
(Date:12/2/2016)... York, NY (PRWEB) , ... December 02, 2016 , ... ... high school and while 84 percent of parents report speaking with their child about ... pornography and sexually transmitted diseases. , Mediaplanet is proud to announce the launch of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical Systems, Inc. ... the first company to offer robotic imaging to veterinary medicine is sponsoring the ... 941 for the American Association of Equine Practitioners 62nd Annual Convention from December ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... "Pro3rd Accents ... FCPX editors to create versatile lower third titles with just a few clicks of ... Accents Volume 2 includes 30 lower third animations. Choose from various styles with accented ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Scientist & Author of Type 2 Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein ... Kleyne Hour Power of Water, Global Climate Change and Your Health radio program ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 Lianluo Smart Limited (Nasdaq: ... which develops, markets and sells medical devices and ... and international markets, recently attended the ... New Progress Forum, co-hosted by the Institute of ... , Guangdong Provincial People,s Hospital and Cardiology Department ...
(Date:12/2/2016)... 1, 2016 The concept of rare diseases and ... to this sector has been taking shape in ... political aspects and initiatives related to orphan medicinal products have ... level of member states individually. Many member states in the ... space of orphan medicinal products, the result of which took ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
Breaking Medicine Technology: